Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Neuropharmacology

Topics

Medicine

Physiology

Internal Medicine

Public Health, Environmental And Occupational Health

Cellular And Molecular Neuroscience

Show all topics

DOI

10.1016/j.neuropharm.2024.110048